12 results
424B5
ONCR
Oncorus, Inc.
19 Nov 21
Prospectus supplement for primary offering
4:41pm
ONCR-021 and ONCR-788,
S-5
we also developed a proprietary LNP platform for delivery of large nucleic acids, with efficient endosomal escape.
We
8-K
EX-99.1
udm6hj
27 May 21
Regulation FD Disclosure
7:15am
DRS
EX-10.21
pntduae
28 Jan 21
Draft registration statement
12:00am
S-1
EX-10.19
82ck7
11 Sep 20
IPO registration
4:49pm
DRS/A
EX-10.19
mep7nw93z3xu4ao7a6
20 Dec 19
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next